BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 21 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 22 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 23 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 2 days ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 21 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 22 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 23 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 2 days ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago
ADVERTISEMENT

CVS Health Corporation (CVS) Q2 2022 Earnings: Key financials and quarterly highlights

CVS Health Corporation (NYSE: CVS) reported second quarter 2022 earnings results today. Total revenues increased 11% year-over-year to $80.6 billion. Net income rose to $2.9 billion, or $2.23 per share, from $2.7 billion, or $2.10 per share, in the year-ago quarter. Adjusted EPS amounted to $2.40. For full-year 2022, adjusted EPS is expected to be […]

$CVS August 3, 2022 1 min read

CVS Health Corporation (NYSE: CVS) reported second quarter 2022 earnings results today.

Total revenues increased 11% year-over-year to $80.6 billion.

Net income rose to $2.9 billion, or $2.23 per share, from $2.7 billion, or $2.10 per share, in the year-ago quarter. Adjusted EPS amounted to $2.40.

For full-year 2022, adjusted EPS is expected to be $8.40-8.60.

Prior performance

ADVERTISEMENT